亚洲 · 区域市场 · CNBC-TV18
Dr Reddy's Laboratories gets USFDA tentative nod for twice-yearly HIV prevention injection
Dr Reddy’s has received USFDA tentative approval for its twice-yearly injectable lenacapavir for HIV prevention, with plans to make it available across 120 countries outside the…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
